Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
11.76
-0.03 (-0.25%)
At close: Oct 13, 2026, 4:00 PM EDT
11.76
0.00 (0.00%)
After-hours: Oct 13, 2026, 4:26 PM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $791.92 million as of October 13, 2026. It is the 11,640th most valuable company in the world and the 2,405th biggest in the United States. Its market cap has increased by 5.68% in one year.
Market Cap
791.92M
Enterprise Value
893.87M
1-Year Change
5.68%
Global Rank
Country Rank
#2,405 United States
Category
ChartMarket Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $791.92M, a decrease of -63.71%. That is a compound annual growth rate of -16.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 791.92M | 67.67% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SpyGlass Pharma | 831.52M |
| Arbutus Biopharma | 821.07M |
| ArriVent BioPharma | 811.61M |
| Helus Pharma | 805.85M |
| Ardelyx | 804.88M |
| Obsidian Therapeutics | 790.08M |
| Sana Biotechnology | 784.32M |
| Geron | 783.82M |